At the time of writing, CAMP4 Therapeutics Corp [CAMP] stock is trading at $2.65, down -18.46%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CAMP shares have gain 60.61% over the last week, with a monthly amount glided 70.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CAMP4 Therapeutics Corp [NASDAQ: CAMP] stock has seen the most recent analyst activity on May 27, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $8. On November 05, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $18 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $23 on November 05, 2024.
For the past year, the stock price of CAMP4 Therapeutics Corp fluctuated between $1.30 and $12.30. Currently, Wall Street analysts expect the stock to reach $12.5 within the next 12 months. CAMP4 Therapeutics Corp [NASDAQ: CAMP] shares were valued at $2.65 at the most recent close of the market. An investor can expect a potential return of 371.7% based on the average CAMP price forecast.
Analyzing the CAMP fundamentals
Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -17.85%, Pretax Profit Margin comes in at -17.22%, and Net Profit Margin reading is -17.22%. To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -1.31 and Total Capital is -1.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that CAMP4 Therapeutics Corp [NASDAQ:CAMP] has a current ratio of 5.60. Also, the Quick Ratio is 5.60, while the Cash Ratio stands at 5.32. Considering the valuation of this stock, the price to sales ratio is 17.75, the price to book ratio is 1.34.
Transactions by insiders
Recent insider trading involved 5AM Partners VI, LLC, 10% Owner, that happened on Sep 11 ’25 when 2.94 million shares were purchased. 10% Owner, Polaris Management Co. VII, L. completed a deal on Sep 11 ’25 to buy 1.31 million shares. Meanwhile, Director Nashat Amir bought 1.31 million shares on Sep 11 ’25.
